SUCCINIC ACID

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
116.0 -2.7 0 4 80.0 3 0.5
UNII
AB6MNQ6J6L
CAS
110-15-6
SYNONYMS
  • Succinic Acid
  • Succinicum Acidum
  • Butanedioic Acid
  • Dihydrofumaric Acid
  • Amber Acid
  • Succinicum Acidum [hpus]
  • Succinic Acid [mart.]
  • Succinic Acid [mi]
  • Succinic Acid [inci]
  • Succinic Acid [fcc]
  • Succinic Acid [ii]
  • Succinic Acid [hsdb]
  • Succinic Acid [usp-Rs]
  • Succinic Acid [who-Dd]
  • Succinic Acid [vandf]
  • Nsc-106449
ZINC ID(s)
Availability
Present in 92 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
EGLN1 Egl nine homolog 1 Enzyme / Enzyme-Other

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT00189800 A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder Phase 3 Completed
NCT02317601 2014-12-01 Preoperative Single Glucocorticoid Hip Fracture Hip Fracture Surgery Phase 4 Not Yet Recruiting
NCT02112916 2014-09-01 Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Phase 3 Recruiting
NCT02176655 2014-07-01 Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches Phase 2 Recruiting
NCT02169713 2014-05-01 Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects Phase 1 Completed
NCT01970501 2014-04-01 Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure Phase 2 Recruiting
NCT02045862 2014-03-01 A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder Phase 3 Enrolling By Invitation
NCT01974934 2013-12-01 Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression Phase 4 Recruiting
NCT02012075 2013-12-01 A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure Phase 3 Recruiting
NCT01977781 2013-12-01 Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease Phase 1 Recruiting
NCT01972841 2013-11-01 This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder Phase 3 Recruiting
NCT01981954 2013-10-01 A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO) Phase 3 Suspended
NCT01970059 2013-10-01 A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension Phase 3 Recruiting
NCT01908829 2013-07-01 A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) Phase 3 Completed
NCT01884857 2013-04-01 Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg Phase 1 Completed
NCT02094703 2013-04-01 The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females Phase 4 Recruiting
NCT01884909 2013-04-01 Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions Phase 1 Completed
NCT01807000 2013-03-01 Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers Phase 1 Completed
NCT01777217 2013-02-01 VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate Phase 4 Terminated
NCT01884896 2013-02-01 Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions Phase 1 Completed
NCT01747577 2012-12-01 Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) Phase 4 Completed
NCT01655069 2012-10-01 A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 Phase 3 Completed
NCT02010944 2012-09-01 A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels Phase 1 Completed
NCT01565707 2012-06-01 A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug Phase 3 Completed
NCT01638000 2012-06-01 A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment Phase 3 Completed
NCT01605370 2012-06-01 Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients? Phase 4 Terminated
NCT01565694 2012-05-01 A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor Overactivity Phase 3 Recruiting
NCT01539707 2012-03-01 Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder Phase 1 Completed
NCT01353963 2012-03-01 Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients Phase 4 Completed
NCT01406756 2012-02-01 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia Phase 3 Recruiting
NCT01676285 2012-01-01 Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis Phase 3 Completed
NCT01372150 2011-11-01 A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD Phase 3 Recruiting
NCT01833663 2011-10-01 Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women Phase 4 Completed
NCT01432457 2011-10-01 Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) Phase 4 Completed
NCT01371994 2011-08-01 A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy Phase 4 Completed
NCT01371734 2011-08-01 A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD Phase 3 Recruiting
NCT01499134 2011-08-01 Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure Phase 3 Completed
NCT01569516 2011-06-01 Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease Phase 2 Recruiting
NCT01406158 2011-05-01 A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation Phase 1 Completed
NCT01340027 2011-03-01 A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder Phase 2 Completed
NCT01694797 2011-01-01 Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition Phase 1 Completed
NCT01673997 2010-12-01 Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions Phase 1 Completed
NCT01486706 2010-10-01 Efficacy and Safety of Gabapentin in Treating Overactive Bladder Phase 4 Active, Not Recruiting
NCT01213173 2010-10-01 Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients Phase 4 Completed
NCT01381120 2010-10-01 Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms Phase 4 Completed
NCT01190514 2010-09-01 Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR) Phase 1 Completed
NCT01501929 2010-08-01 Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients Phase 4 Recruiting
NCT01189500 2010-08-01 Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects Phase 4 Completed
NCT01188668 2010-08-01 Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects Phase 4 Completed
NCT01121484 2010-06-01 Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) Phase 4 Completed
NCT00952653 2010-06-01 Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam Phase 4 Completed
NCT01101152 2010-04-01 Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers Phase 1 Recruiting
NCT01021332 2010-04-01 Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms Phase 3 Completed
NCT01056289 2010-03-01 Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) Phase 4 Completed
NCT01018264 2010-01-01 Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease Phase 4 Active, Not Recruiting
NCT01018511 2010-01-01 Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms Phase 3 Completed
NCT01381796 2009-12-01 Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults Phase 1 Completed
NCT01041287 2009-12-01 Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells Phase 4 Completed
NCT01015040 2009-09-01 Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers Phase 1 Completed
NCT00893737 2009-06-01 """Completeness of Response"" Following Treatment With Treximet™ for Migraine" Phase 4 Completed
NCT00887224 2009-06-01 Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder Phase 3 Completed
NCT00888862 2009-06-01 Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women Phase 3 Recruiting
NCT00920686 2009-06-01 Study of NXN 188 for the Treatment of Migraine With Aura Phase 2 Completed
NCT01502787 2009-04-01 Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients Phase 4 Completed
NCT00863798 2009-04-01 Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder Phase 3 Completed
NCT00831415 2009-03-01 Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD) Phase 3 Completed
NCT01297192 2009-03-01 A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously Phase 1 Completed
NCT00824291 2009-02-01 Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder Phase 3 Completed
NCT01005758 2009-01-01 Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Phase 2 Not Yet Recruiting
NCT00818155 2009-01-01 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females Phase 1 Completed
NCT00798707 2008-12-01 Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder Phase 3 Completed
NCT00796315 2008-12-01 Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children Phase 1 Completed
NCT00773552 2008-11-01 Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder Phase 4 Not Yet Recruiting
NCT00723983 2008-11-01 Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period Phase 1 Completed
NCT00771394 2008-10-01 Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia Phase 4 Completed
NCT00720109 2008-07-01 Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Phase 3 Active, Not Recruiting
NCT00727064 2008-06-01 Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects Phase 1 Completed
NCT00683800 2008-06-01 Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women Phase 3 Completed
NCT00669110 2008-05-01 Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder Phase 2 Completed
NCT00629642 2008-03-01 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Phase 4 Completed
NCT00619619 2008-02-01 Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder Phase 2 Completed
NCT00614445 2008-01-01 The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy Phase 3 Completed
NCT00584090 2007-11-01 Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease Phase 4 Withdrawn
NCT00546650 2007-11-01 Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® Phase 1 Completed
NCT00573508 2007-08-01 Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life Phase 4 Completed
NCT00510419 2007-07-01 A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack Phase 3 Completed
NCT00507455 2007-06-01 Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction Phase 2 Completed
NCT00627731 2007-06-01 Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients Phase 4 Completed
NCT00476190 2007-04-01 ALL Adult Consortium Trial: Adult ALL Trial Phase 2 Active, Not Recruiting
NCT00510406 2007-01-01 A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH Phase 2 Completed
NCT00433043 2007-01-01 BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT) Phase 4 Terminated
NCT00401245 2006-12-01 The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms Phase 3 Completed
NCT00406640 2006-12-01 Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women Phase 3 Completed
NCT00397176 2006-11-01 Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women Phase 1 Completed
NCT00383162 2006-11-01 A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) Phase 3 Completed
NCT00391846 2006-10-01 Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone Phase 4 Completed
NCT00384033 2006-09-01 Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder Phase 3 Completed
NCT00368706 2006-09-01 A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients Phase 3 Completed
NCT00387881 2006-09-01 TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) Phase 3 Completed
NCT00369343 2006-09-01 Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women Phase 3 Completed
NCT00385008 2006-09-01 TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine Phase 3 Completed
NCT01050218 2006-07-01 Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy Phase 3 Terminated
NCT00356603 2006-06-01 Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan Phase 3 Completed
NCT00369434 2006-06-01 Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women Phase 3 Completed
NCT00333112 2006-05-01 A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. Phase 4 Completed
NCT00337558 2006-05-01 A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) Phase 4 Completed
NCT01248338 2006-03-01 Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function Phase 4 Completed
NCT00273052 2006-01-01 COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension Phase 3 Completed
NCT00861016 2005-10-01 Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension Phase 4 Completed
NCT00661895 2005-08-01 Black Education and Treatment of Hypertension (BEAT HTN) Phase 4 Completed
NCT00250653 2005-05-01 A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression Phase 3 Completed
NCT00250614 2005-04-01 An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression Phase 3 Completed
NCT00250601 2005-04-01 An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression Phase 3 Completed
NCT00250627 2004-12-01 An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression Phase 3 Completed
NCT00097448 2004-12-01 Sudden Deafness Treatment Trial Phase 3 Completed
NCT00256113 2004-12-01 An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression Phase 3 Completed
NCT00650247 2004-11-01 Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg Phase 1 Completed
NCT00648466 2004-11-01 Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg Phase 1 Completed
NCT01052428 2004-08-01 Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease) Phase 2/Phase 3 Completed
NCT00846885 2004-08-01 Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions Phase 1 Completed
NCT00166400 2004-07-01 A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation. Phase 4 Completed
NCT00463541 2004-06-01 Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms Phase 3 Completed
NCT00057811 2004-06-01 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Phase 2 Completed
NCT00454740 2004-06-01 Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder Phase 3 Completed
NCT00801944 2004-04-01 Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms Phase 3 Completed
NCT00290602 2004-02-01 Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome Phase 2 Completed
NCT02242812 2003-09-01 Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension Phase 4 Terminated
NCT01309542 2003-08-01 Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder Phase 3 Completed
NCT00077948 2003-07-01 Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure Phase 3 Terminated
NCT00802373 2003-07-01 Solifenacin Succinate Versus Tolterodine 4mg Once Daily Phase 3 Completed
NCT00642096 2003-06-01 Factorial Study of Metoprolol Succinate TOPROL-XL (324A) Phase 3 Completed
NCT00847405 2003-03-01 Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions Phase 1 Completed
NCT02264002 2003-02-01 Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers Phase 1 Completed
NCT01167946 2003-01-01 Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata Phase 4 Completed
NCT00648778 2003-01-01 Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg Phase 1 Completed
NCT00255502 2002-07-01 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects Phase 3 Completed
NCT00255528 2002-07-01 Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects Phase 3 Completed
NCT00147004 2002-03-01 Corticosteroid Therapy of Septic Shock - Corticus Phase 3 Completed
NCT01798992 2000-09-01 Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart Phase 4 Completed

(Browse) Purchasable Analogs in ZINC

Functions of Succinic Acid

Misc - Miscellaneous

Regulatory Status of Succinic Acid

Gras - Generally recognized as safe.

Products Using Succinic Acid

Download
APIs Products incorporating these APIs
Amoxicillin , Clavulanic Acid Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX)
Amoxicillin , Clavulanate Potassium Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX) , Amoxicillin And Clavulanate Potassium(RX)
Ciprofloxacin Hydrochloride , Ciprofloxacin Ciprofloxacin(DISCN) , Cipro(DISCN)
Methylphenidate Hydrochloride Concerta(RX) , Methylphenidate Hydrochloride(RX) , Methylphenidate Hydrochloride(RX) , Methylphenidate Hydrochloride(RX) , Concerta(RX) , Methylphenidate Hydrochloride(RX) , Methylphenidate Hydrochloride(RX)
Ibuprofen Leader Ibuprofen(OTC) , Leader Ibuprofen(OTC) , Ibuprofen(OTC) , Sunmark Ibuprofen Ib(OTC) , Ibuprofen Junior Strength(OTC) , Ibuprofen(OTC) , Ibuprofen Junior(OTC) , Leader Ibuprofen(OTC) , Shoprite Ibuprofen Ib(OTC) , Good Sense Ibuprofen(OTC) , Signature Care Ibuprofen(OTC) , Rexall Ibuprofen(OTC) , Good Neighbor Pharmacy Ibuprofen(OTC) , Good Neighbor Pharmacy Ibuprofen(OTC) , Ibuprofen(OTC) , Good Sense Ibuprofen(OTC) , Ibuprofen(OTC) , Healthy Accents Ibuprofen(OTC) , Care One Ibuprofen Junior Strength(OTC) , Leader Ibuprofen(OTC) , Leader Ibuprofen(OTC) , Good Sense Ibuprofen(OTC) , Junior Strength Ibuprofen(OTC) , Health Mart Ibuprofen(OTC) , Ibuprofen(OTC) , Ibuprofen(OTC) , Topcare Ibuprofen Junior Strength(OTC) , Ibuprofen(OTC) , Equaline Ibuprofen(OTC) , Ibuprofen(OTC) , Ibuprofen(OTC) , Junior Strength Ibuprofen(OTC) , Up And Up Ibuprofen Junior(OTC) , Ibuprofen(OTC) , Up And Up Junior Strength Ibuprofen(OTC) , Careone Ibuprofen Junior Strength(OTC) , Ibuprofen(OTC) , Smart Sense Ibuprofen(OTC) , Ibuprofen(OTC) , Equate Ibuprofen(OTC) , Healthy Accents Ibuprofen(OTC) , Ibuprofen Junior Strength(OTC)

Dosages

Route Formulation Per Unit Dose
Im - Iv Injection
Intravenous Injection
Oral Concentrate 0.6%
Oral Powder, For Oral Suspension 0.02%
Oral Powder, For Reconstitution 0.04%
Oral Powder, For Suspension
Oral Solution 0.001%
Oral Tablet 65.1MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 2.86MG
Oral Tablet, Controlled Release 4MG
Oral Tablet, Extended Release

More Information

Usage Over Time

Comments